{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:58:49Z","timestamp":1791907129385,"version":"4.3.4"},"reference-count":25,"publisher":"The Endocrine Society","issue":"6","funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,1]]},"DOI":"10.1210\/jc.2018-01965","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T19:48:58Z","timestamp":1550087338000},"page":"2443-2452","source":"Crossref","is-referenced-by-count":85,"title":["Invasive Oral Procedures and Events in Postmenopausal Women With Osteoporosis Treated With Denosumab for Up to 10 Years"],"prefix":"10.1210","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0719-9801","authenticated-orcid":false,"given":"Nelson B","family":"Watts","sequence":"first","affiliation":[{"name":"Osteoporosis and Bone Health Services Division, Mercy Health, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T","family":"Grbic","sequence":"additional","affiliation":[{"name":"Division of Foundational Sciences, Columbia University College of Dental Medicine, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Binkley","sequence":"additional","affiliation":[{"name":"Divisions of Geriatrics and Endocrinology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socrates","family":"Papapoulos","sequence":"additional","affiliation":[{"name":"Center for Bone Quality, Leiden University Medical Center, Leiden, Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W","family":"Butler","sequence":"additional","affiliation":[{"name":"Global Development, Amgen Inc., Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Yin","sequence":"additional","affiliation":[{"name":"Global Biostatistical Science, Amgen Inc., Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoniette","family":"Tierney","sequence":"additional","affiliation":[{"name":"Global Safety, Amgen Inc., Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel B","family":"Wagman","sequence":"additional","affiliation":[{"name":"Global Development, Amgen Inc., Thousand Oaks, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McClung","sequence":"additional","affiliation":[{"name":"Oregon Osteoporosis Center, Portland, Oregon"},{"name":"Mary MacKillop Institute for Health Research, Australian Catholic University, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2019,2,13]]},"reference":[{"issue":"9","key":"2019050908293492000_B1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"issue":"9768","key":"2019050908293492000_B2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"issue":"9","key":"2019050908293492000_B3","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1200\/JCO.2010.31.3304","article-title":"Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma","volume":"29","author":"Henry","year":"2011","journal-title":"J Clin Oncol"},{"issue":"11","key":"2019050908293492000_B4","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.14219\/jada.archive.2010.0082","article-title":"The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program","volume":"141","author":"Grbic","year":"2010","journal-title":"J Am Dent Assoc"},{"issue":"7","key":"2019050908293492000_B5","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"2019050908293492000_B6","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"5","key":"2019050908293492000_B7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.joms.2009.01.009","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"issue":"10","key":"2019050908293492000_B8","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"issue":"8","key":"2019050908293492000_B9","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"issue":"3","key":"2019050908293492000_B10","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jbmr.1479","article-title":"Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension","volume":"27","author":"Papapoulos","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"11","key":"2019050908293492000_B11","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1210\/jc.2013-1597","article-title":"The effect of three or six years of denosumab exposure in women with postmenopausal osteoporosis: results from the FREEDOM extension","volume":"98","author":"Bone","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2019050908293492000_B12","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1007\/s00198-015-3179-x","article-title":"Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years","volume":"26","author":"Ferrari","year":"2015","journal-title":"Osteoporos Int"},{"issue":"12","key":"2019050908293492000_B13","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00198-015-3234-7","article-title":"The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study","volume":"26","author":"Papapoulos","year":"2015","journal-title":"Osteoporos Int"},{"issue":"9","key":"2019050908293492000_B14","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S1470-2045(10)70170-4","article-title":"Safety of denosumab in giant-cell tumour of bone","volume":"11","author":"Thomas","year":"2010","journal-title":"Lancet Oncol"},{"issue":"17","key":"2019050908293492000_B15","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1200\/JCO.2011.35.2203","article-title":"Reply to V. Fusco et al","volume":"29","author":"Stopeck","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019050908293492000_B16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00256-008-0549-x","article-title":"Osteonecrosis of the jaw","volume":"38","author":"Reid","year":"2009","journal-title":"Skeletal Radiol"},{"key":"2019050908293492000_B17","author":"Hess"},{"issue":"28","key":"2019050908293492000_B18","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1200\/JCO.2008.16.2768","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients","volume":"26","author":"Kyrgidis","year":"2008","journal-title":"J Clin Oncol"},{"issue":"32","key":"2019050908293492000_B19","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","article-title":"Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw","volume":"27","author":"Vahtsevanos","year":"2009","journal-title":"J Clin Oncol"},{"issue":"6","key":"2019050908293492000_B20","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.joms.2009.02.004","article-title":"Clinical investigation of C-terminal cross-linking telopeptide test in prevention and management of bisphosphonate-associated osteonecrosis of the jaws","volume":"67","author":"Kunchur","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"2019050908293492000_B21","doi-asserted-by":"crossref","first-page":"182513","DOI":"10.1155\/2014\/182513","article-title":"Risk factors of periodontal disease: review of the literature","volume":"2014","author":"AlJehani","year":"2014","journal-title":"Int J Dent"},{"issue":"10","key":"2019050908293492000_B22","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1210\/jc.2015-1794","article-title":"Declining Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Cancer","volume":"100","author":"Sim","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2019050908293492000_B23","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/jbmr.3337","article-title":"Vertebral fractures after discontinuation of denosumab: a post hoc analysis of the randomized placebo-controlled FREEDOM trial and its extension","volume":"33","author":"Cummings","year":"2018","journal-title":"J Bone Miner Res"},{"key":"2019050908293492000_B24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bone.2017.12.015","article-title":"Rebound vertebral fracture in the dental chair during a tooth extraction whilst on a treatment holiday from denosumab to avoid ONJ","volume":"108","author":"Leaney","year":"2018","journal-title":"Bone"},{"issue":"9","key":"2019050908293492000_B25","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.4158\/EP161435.ESGL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis - 2016\u2013executive summary","volume":"22","author":"Camacho","year":"2016","journal-title":"Endocr Pract"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/6\/2443\/28574076\/jc.2018-01965.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T09:15:28Z","timestamp":1557393328000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/6\/2443\/5316168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,13]]},"references-count":25,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,2,13]]},"published-print":{"date-parts":[[2019,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2018-01965","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735106799.793562966","asserted-by":"object"}]},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6]]},"published":{"date-parts":[[2019,2,13]]}}}